GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

Rating:
Outperform
ALXN
up 1,760.52 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Outperform by Leerink Swann

Posted on: Monday,  Feb 9, 2009  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 02/09/2009, when the stock price was $9.67.
Since then, Alexion Pharmaceuticals, Inc. has gained 1760.53% as of 12/11/2015's recent price of $179.82.
If you would have followed this Leerink Swann 's recommendation on ALXN, you would have gained 1760.52% of your investment in 2496 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/9/2009 8:25 AM Buy
None
9.67
as of 12/31/2009
1 Week up  74.19 %
1 Month up  86.05 %
3 Months up  89.55 %
1 YTD up  118.39 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy